GO
| HSI1 | 26,485.90 | +550.49 | 234.65B |
| HSCEI1 | 9,355.97 | +192.73 | 85.09B |
| Back Zoom + Zoom - Block Traded | |
|
2025-11-06 17:51:42 Singapore's biopharmaceutical company Hummingbird Bioscience is weighing a listing in Hong Kong next year, Reuters' IFR reported, citing sources. The company, founded in 2015, focuses on developing innovative cancer treatment drugs. ~ AASTOCKS Financial News Website: www.aastocks.com | |